These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Metabolic complications of antiretroviral therapy of HIV infection]. Goebel FD; Walli R Dtsch Med Wochenschr; 2000 Jun; 125(24):771-3. PubMed ID: 10902517 [No Abstract] [Full Text] [Related]
8. [Antiretroviral therapy in adult HIV-infected patients]. Salzberger B; Schrappe M; Diehl V Internist (Berl); 1994 Dec; 35(12):1095-104. PubMed ID: 7883513 [No Abstract] [Full Text] [Related]
9. [Treatment of HIV/AIDS. New possibilities result in new problems]. Nielsen JO Ugeskr Laeger; 1998 Jun; 160(23):3371. PubMed ID: 9627502 [No Abstract] [Full Text] [Related]
10. Switching antiretroviral therapy: why, when and how. Wilkin T; Glesby M; Gulick RM IAPAC Mon; 2006 Jul; 12(7):220-9. PubMed ID: 17096494 [No Abstract] [Full Text] [Related]
11. Early antiretroviral treatment of HIV not found beneficial. Todays OR Nurse; 1994; 16(4):58. PubMed ID: 8066597 [No Abstract] [Full Text] [Related]
12. Metabolic consequences and therapeutic options in highly active antiretroviral therapy in human immunodeficiency virus-1 infection. Samaras K J Antimicrob Chemother; 2008 Feb; 61(2):238-45. PubMed ID: 18070830 [TBL] [Abstract][Full Text] [Related]
13. [Award of the 2003 AIDS Prize. Why doesn HAART therapy induce lipodystrophy in HIV positive patients?]. HNO; 2003 Jul; 51(7):543. PubMed ID: 12916494 [No Abstract] [Full Text] [Related]
14. Into the future: HIV therapy advances. Introduction. Carosi G AIDS; 1994 Sep; 8 Suppl 3():S1-2. PubMed ID: 7840909 [No Abstract] [Full Text] [Related]
15. [Protease inhibitor-associated hypertriglyceridemia and diabetes mellitus in HIV-infected patients]. Knobel H; Goday A; Grau S Med Clin (Barc); 1998 Nov; 111(15):599. PubMed ID: 9859098 [No Abstract] [Full Text] [Related]
16. [Delayed virus suppression has its price. Heart and liver are no longer secondary theaters]. MMW Fortschr Med; 2002 Apr; 144 Suppl 1():12-4. PubMed ID: 12043063 [No Abstract] [Full Text] [Related]
17. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia. Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343 [TBL] [Abstract][Full Text] [Related]
18. [Staying on antiviral treatment of HIV-infected children]. Vaudre G; Martelet S; Dollfus C Soins Pediatr Pueric; 2000; (194):29-31. PubMed ID: 11190173 [No Abstract] [Full Text] [Related]
19. Clinical significance of treatment-induced lipid abnormalities and lipodystrophy. Smith D J HIV Ther; 2001 May; 6(2):25-7. PubMed ID: 11501199 [No Abstract] [Full Text] [Related]
20. Antiretroviral protease inhibitor therapy leads to hyperglycaemia, hyperlipidaemia and lipodystrophy. Sangraula H; Sharma KK; Dwivedi S Natl Med J India; 2001; 14(6):347-8. PubMed ID: 11804366 [No Abstract] [Full Text] [Related] [Next] [New Search]